← FDA Drug Approvals (Drugs@FDA)

FASLODEX

NDA · New Drug Application · Sponsor: ASTRAZENECA · Approved 2002-04-25

Drug application

FDA Application #

NDA021344

Application type

New Drug Application

Brand name

FASLODEX

Generic name

FULVESTRANT

Active ingredients

FULVESTRANT

Dosage form

SOLUTION

Route

INTRAMUSCULAR

Marketing status

Prescription

Sponsor

ASTRAZENECA

Manufacturer

AstraZeneca Pharmaceuticals LP

First approval

2002-04-25

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown